Save time and get answers to complex questions with AI chat
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Tenofovir generic patent?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Can wine consumption affect lipitor's cholesterol lowering ability?Antiox mebendazole price?
See the DrugPatentWatch profile for Spiriva
Spiriva Respimat is a brand name for a tiotropium inhalation medicine made for long-term treatment of breathing problems.
Spiriva Respimat is prescribed to help control symptoms and reduce exacerbations in chronic obstructive pulmonary disease (COPD) and to manage symptoms in asthma when used as an add-on controller therapy.
The active ingredient in Spiriva Respimat is tiotropium (a long-acting anticholinergic, or LAMA).
Spiriva Respimat is marketed under the Boehringer Ingelheim brand.
They are related but not identical products. “Spiriva” is used as the general brand name for tiotropium inhalers, while “Spiriva Respimat” specifically refers to the Respimat inhaler device and its corresponding formulation/dosing. Sources: [1] https://www.drugs.com/spiriva-respimat.html
Other Questions About Spiriva :